Currently, out of the existing stock ratings of Dominic Lunn - 2 which are a Sell (100%)

Dominic Lunn

Work Performance Price Targets & Ratings Chart

Analyst Dominic Lunn works at CREDIT SUISSE and is covering the Healthcare sector with 17 price targets and ratings displayed on 5 stocks.

Dominic Lunn's average stock forecast success ratio is 58.33% with an average time for price targets to be met of 29 days.

Most recent stock forecast was given on NVO, at 03-Nov-2022.

Wall Street Analyst Dominic Lunn

Analyst best performing recommendations are on NVO.
The best stock recommendation documented was for NVO at 8/23/2021. The price target of $98.74 was fulfilled within 17 days with a profit of $5.92 (5.66%) receiving and performance score of 3.33.

Average potential price target upside

GSK GlaxoSmithKline plc NVO NVS Novartis AG AZN AstraZeneca PLC SNY

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Sell

29.46

2 months 14 days ago

1/2 (50%)

$-14.42 (-33.60%)

215

Hold

18.14

$-18.9 (-51.03%)

18.9

7 months 25 days ago

0/8 (0%)

$-16.44 (-44.15%)

Sell

17.1

$-19.94 (-53.83%)

24.14

7 months 26 days ago

0/9 (0%)

$-17.22 (-44.81%)

Hold

19.72

$-17.32 (-46.76%)

8 months 24 days ago

0/1 (0%)

$-14.97 (-43.15%)

Hold

20.87

$-16.17 (-43.66%)

18.29

9 months 20 days ago

0/2 (0%)

$-14.24 (-42.07%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Dominic Lunn?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart